WallStreetZenWallStreetZen

NASDAQ: MCRB
Seres Therapeutics Inc Stock Ownership - Who owns Seres Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Seres Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Matthew R. HennChief Scientific Officer and EVP2025-02-183,953$0.81
$3.20kSell
Moltke Lisa VonExecutive Vice President and Chief Medical Officer2025-02-184,416$0.81
$3.58kSell
Thomas DesrosierChief Legal Officer and EVP2025-02-184,300$0.81
$3.48kSell
Eric D. ShaffCEO and President2025-02-1812,726$0.81
$10.31kSell
Teresa L. YoungEVP Chief Commercial Strategy Officer2025-02-183,338$0.81
$2.70kSell
Teresa L. YoungEVP Chief Commercial Strategy Officer2024-11-18735$0.54
$397.64Sell
Eric D. ShaffCEO and President2024-11-182,505$0.54
$1.36kSell
Thomas DesrosierChief Legal Officer and EVP2024-11-18878$0.54
$475.00Sell
Matthew R. HennChief Scientific Officer and EVP2024-11-18927$0.54
$501.51Sell
Moltke Lisa VonExecutive Vice President and Chief Medical Officer2024-11-18977$0.54
$528.56Sell

1 of 3

MCRB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MCRB insiders and whales buy or sell their stock.

MCRB Shareholders

What type of owners hold Seres Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Nutritional Health Ltp Fund General Partner LLC13.69%23,869,081$8.83MInsider
Flagship Pioneering Inc13.26%23,117,045$8.55MInstitution
Sa Nestle12.55%21,879,753$8.10MInsider
Fmr LLC12.51%21,811,697$8.07MInstitution
Nestle Health Science Us Holdings Inc3.95%6,888,888$2.55MInsider
Vanguard Group Inc3.37%5,873,880$2.17MInstitution
Flagship Pioneering Fund VII General Partner LLC3.34%5,825,495$2.16MInsider
Flagship Pioneering Inc2.55%4,444,444$1.64MInsider
Noubar Afeyan1.58%2,750,135$1.02MInsider
Morgan Stanley1.15%2,013,251$744.90kInstitution

1 of 3

MCRB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MCRB36.18%38.77%Net SellingNet Selling
INO30.11%69.89%Net SellingNet Selling
PYXS51.20%37.91%Net Buying
BMEA57.06%42.94%Net Buying
ABOS70.15%17.11%Net SellingNet Selling
View Top Biotech Stocks

Seres Therapeutics Stock Ownership FAQ

Who owns Seres Therapeutics?

Seres Therapeutics (NASDAQ: MCRB) is owned by 36.18% institutional shareholders, 38.77% Seres Therapeutics insiders, and 25.05% retail investors. Nutritional Health Ltp Fund General Partner LLC is the largest individual Seres Therapeutics shareholder, owning 23.87M shares representing 13.69% of the company. Nutritional Health Ltp Fund General Partner LLC's Seres Therapeutics shares are currently valued at $8.93M.

If you're new to stock investing, here's how to buy Seres Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.